Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
martin_lavoie [2022/04/21 23:55] liam | martin_lavoie [2022/04/22 00:16] (current) liam |
---|
| |
While at AHS, Lavoie advocated for people to get the [[influenza vaccine|influenza vaccines]].((Luedee, T., & Ziegler, C. (2015, December 10). //Spread joy, not germs: stay healthy this holiday season.// Alberta Health Services. https://www.albertahealthservices.ca/news/releases/2015/Page12879.aspx)) | While at AHS, Lavoie advocated for people to get the [[influenza vaccine|influenza vaccines]].((Luedee, T., & Ziegler, C. (2015, December 10). //Spread joy, not germs: stay healthy this holiday season.// Alberta Health Services. https://www.albertahealthservices.ca/news/releases/2015/Page12879.aspx)) |
| |
| ==== University of Alberta ==== |
| |
| Lavoie is an Assistant Clinical Professor in the Department of Medicine at the [[University of Alberta]]. |
| |
==== Fraser Health Authority ==== | ==== Fraser Health Authority ==== |
| |
===== Research ===== | ===== Research ===== |
| |
| ==== Influenza ==== |
| |
| Lavoie has participated in research on [[H1N1]] influenza, including in collaboration with the [[National Microbiology Laboratory]] under the [[Public Health Agency of Canada]] and the [[Center for Disease Control and prevention|Centers for Disease Control and Prevention]] (CDC) in the United States.((Howden, K. J., Brockhoff, E. J., Caya, F. D., McLeod, L. J., Lavoie, M., Ing, J. D., Bystrom, J. M., Alexandersen, S., Pasick, J. M., Berhane, Y., Morrison, M. E., Keenliside, J. M., Laurendeau, S., & Rohonczy, E. B. (2009). //An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm.// The Canadian veterinary journal = La revue veterinaire canadienne, 50(11), 1153–1161.)) |
| |
==== Funding ==== | ==== Funding ==== |
| |
Lavoie has participated in research funded by the [[Alberta Innovates]] Health Solutions Team Collaborative Innovation Opportunity. AI is partnered with [[pharmaceutical_companies:Pfizer]].((//2020/21 Annual Report.// (2021, August). Alberta Innovates. https://albertainnovates.ca/app/uploads/2021/08/AI-2020-21-ANNUAL-REPORT_WEB-1.pdf)) | Lavoie has participated in research funded by the [[Alberta Innovates]] Health Solutions Team Collaborative Innovation Opportunity. AI is partnered with [[pharmaceutical_companies:Pfizer]].((//2020/21 Annual Report.// (2021, August). Alberta Innovates. https://albertainnovates.ca/app/uploads/2021/08/AI-2020-21-ANNUAL-REPORT_WEB-1.pdf)) Further funding has come from the [[Alberta Children's Hospital Research Institute]], the [[Women and Children's Health Research Institute]], and the [[Alberta Children's Hospital Foundation]]. |
| |
| ===== Presentations ===== |
| |
| Lavoie was a presenter at the [[British Columbia Pharmacy Association]] (BCPhA) 2021 Conference, where he discussed [[COVID-19 vaccines]]. The conference is sponsored by [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Janssen]], [[London Drugs]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Pharmascience]], [[pharmaceutical_companies:Sandoz]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Seqirus]], [[pharmaceutical_companies:Takeda]], [[pharmaceutical_companies:Trudell]], and [[pharmaceutical_companies:Unipharm]].((//Sponsors.// BC Pharmacy Association. Retrieved April 21, 2022, from https://archive.ph/IYo7e)) |